| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Virnich Daniel | Chief Executive Officer | C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD, SUITE 800, CERRITOS | /s/ Mark Hueppelsheuser, Attorney-in-Fact for Daniel Virnich | 2025-05-22 | 0001891107 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TOI | Common stock | Disposed to Issuer | -$54.5K | -20.4K | -1.13% | $2.68 | 1.79M | May 21, 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement. |